Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Evolution of incretin-based therapies: From GLP-1 monotherapy to dual and triple agonists
To learn more about AOD-9604 or discuss whether its safety profile aligns with your health situation and goals, consider consulting with a healthcare provider experienced in peptide therapy applications
Whats happening: Weeks of targeted fat metabolism reach their peak
Compared to Growth Hormone Secretagogues: Peptides like ipamorelin and CJC-1295/ipamorelin combinations work by stimulating natural growth hormone release, producing IGF-1 elevation and the associated growth hormone effects
[8] Early small-scale research suggested it may stimulate lipolysis (the breakdown of fat) and inhibit lipogenesis (fat storage), with preliminary data indicating it may not significantly affect blood glucose or insulin-like growth factor-1 (IGF-1) levels
In 2014, the US Food and Drug Administration (FDA) acknowledged a GRAS (Generally Recognised as Safe) notification for AOD 9604 as a food ingredient meaning the FDA raised no questions about the notifier's own safety conclusion
US$ 20.82
US$ 24.88
US$ 24.94
US$ 22.08
US$ 21.74
US$ 20.18
